Spinal muscular atrophy (SMA) is a motor neuron disorder resulting from anterior horn cell death. Survival motor neuron (SMN) is the SMA-determining gene and is deleted or gene converted in >95% of SMA patients. The SMN protein has a role in spliceosomal snRNP biogenesis and has therefore been implicated indirectly in general cellular RNA processing due to its unique sub-nuclear localization within structures termed 'gems', which co-localize with spliceosomal factors within coiled bodies. In this report, direct SMN RNAbinding activity, in addition to ssDNA and dsDNA binding is demonstrated. The region of SMN encoded by exon 2 is necessary and sufficient to mediate its nucleic acid-binding activities. This domain is homologous to several nucleic acid-binding factors, including several high mobility group (HMG) proteins. Additionally, previously reported SMN missense mutations isolated from SMA patients demonstrated reduced RNAbinding activity, suggesting that nucleic acid binding is functionally significant.
INTRODUCTION
Spinal muscular atrophy (SMA) is a motor neuron disorder resulting from anterior horn cell death. The autosomal recessive form has a carrier frequency of 1:50 and is the most common genetic cause of infant death (1) . SMA is clinically categorized as types I, II or III based on age of onset and clinical progression. Type I (severe) patients have onset of weakness within the first 6 months of life and typically die within the first 2 years. Type II (intermediate) patients experience symptoms before age 2 and never walk unassisted. Type III (mild) patients exhibit less severe clinical symptoms with a highly variable age of onset.
The gene responsible for all three types of SMA was mapped to chromosome 5q11.2-q13.3 (2) (3) (4) , and subsequently was identified as survival motor neuron (SMN) (5) . Within this region, ∼500 kb containing several genes and genetic markers is duplicated and inverted (5) (6) (7) (8) . Two duplicate, inverted copies of SMN typically are present in humans; a telomeric (SMN tel ) and a centromeric (SMN cen ) copy. The two SMN genes and their predicted proteins are identical except for five silent, though distinguishing, nucleotide differences located in the 3′ region of the genes (for review see refs 8, 9) . Interestingly, only deletions or intragenic mutations of SMN tel correspond to the clinical development of SMA, while SMN cen mutations do not result in SMA (5, 8, 9) . Both SMN genes produce a full-length transcript that contains nine exons encoding a 294 amino acid protein. Three alternatively spliced transcripts have been detected; SMN∆5, SMN∆7 and SMN∆5,7, which lack exon 5, 7 or both, respectively. SMN tel produces primarily the full-length form and no detectable levels of SMN∆7. In contrast, SMN∆7 is believed to be the primary product of SMN cen (5, 10) .
Initial observations identified SMN protein within unique, discrete subnuclear structures, termed 'gems'. These are adjacent to coiled bodies, which contain components of the cellular RNA processing machinery (11) . Recently, SMN, in association with SMN-interacting protein 1 (SIP1), has been shown to play a critical function in the biogenesis of spliceosomal snRNPs (12, 13) . Additionally, SMN-SIP1 complexes were shown to be associated specifically with U1 and U5 snRNA (12, 13) ; however, no evidence of direct SMN-RNA binding activity has been reported.
The mechanism(s) underlying the specific temporal and spatial SMN defect associated with SMA remains elusive. Potentially, the identification of specific SMN-regulated genes would provide tremendous insight into an α-motor neuron-specific defect. With this goal, we sought to characterize the interaction of the SMN protein with RNA and DNA. The SMN exon 2 region encodes a potent nucleic acid-binding domain (NBD) that is necessary and sufficient to mediate RNA-and DNA-binding activity. This region shows a high degree of conservation across species, and is homologous to several high mobility group (HMG) proteins. Finally, SMN missense mutations isolated from type I and type II SMA patients decrease SMN RNA-binding activity, further suggesting that nucleic acid binding is functionally significant.
RESULTS
SMN has been shown to participate in large protein-RNA complexes with SIP1 and specific snRNAs (12, 13) . To determine whether SMN directly binds RNA, a series of in vitro binding assays were developed. 35 S-radiolabeled SMN protein was generated in reticulocyte lysates in coupled transcription-translation (TnT) reactions, and was assayed for its ability to bind RNA homopolymer-coupled agarose beads ( Fig. 1A ). SMN associated *To whom correspondence should be addressed. Tel: +1 617 636 1493; Fax: +1 617 636 6190; Email: eandroph@opal.tufts.edu very efficiently with the poly(rG) even in the presence of 500 mM NaCl (Fig. 1A , lanes 5-7), thereby identifying stable RNA-binding activity within SMN. SMN association with poly(rC), poly(rA) and poly(rU) (Fig. 1A , lanes 1-3, 9-11 and 13-15, respectively), was detectable, though substantially reduced. TnT-expressed luciferase, a negative control, failed to associate with any RNA homopolymer even in the presence of the lowest NaCl concentration tested.
To identify the domain(s) in SMN that mediates RNA binding, and to preclude the possibility that cellular factors present in reticulocyte lysate indirectly mediated the interaction between SMN and RNA, full-length wild-type SMN and multiple SMN regions were overexpressed in Escherichia coli as glutathione S-transferase (GST) fusion proteins (Fig. 1C ). Equivalent amounts of each fusion protein were then assayed for their RNA-binding activity by reacting ∼1.0 µg of each fusion protein with [α-32 P]UTP-radiolabeled RNA spanning the SMN exon 1 sense strand. Full-length SMN, as well as N-terminal segments comprised of exons 1-4, 1-3 and 1-2, displayed RNA-binding activity (Fig. 1B, lanes 1 and 4-6 ). The fusion proteins limited to exons 6 and 7 (Fig. 1B , lanes 2 and 3), which mediate SMN self-oligomerization (14) , failed to associate with the RNA probe. RNA-binding activity was retained in all constructs containing SMN exon 2a and b, which was shown to be not only necessary, but sufficient for SMN RNA-binding activity (Fig. 1B, lane 8) . SMN RNA-binding activity was similar for alternate probes of different lengths and sequence composition (data not shown). Equivalent amounts of GST or GST-Fyn, a non-specific protein, failed to bind detectable levels of the RNA probe. SMN and U1A (15), a cellular RNA-binding protein, exhibited similar nonsequence-specific binding activity over a range of NaCl concentrations, as determined by their abilities to bind a RNA probe corresponding to the pcDNA3 polylinker region (Fig. 1D ). [ 35 S]methionine-radiolabeled full-length SMN and luciferase proteins were expressed in reticulocyte lysates and reacted with equivalent amounts of each agarose-linked RNA homopolymer (Pharmacia) [lanes 1-4, poly(rC); 5-8, poly(rG); 9-12, poly(rA); 13-16, poly(rT)] in 400 ml of RNA binding buffer (RBB) (100, 200 or 500 mM NaCl) at 4_C for 10 min. Bound fractions were resolved by 14% SDS-PAGE. Luciferase bindings were performed at 100 mM NaCl. Ten percent of the TnT amount added to each binding reaction is shown on the right portion of the panel. Two SMN species were observed due to an internal initiation event. (B) Identification of the SMN-RNA binding domain. Equivalent amounts of sense strand RNA corresponding to SMN exon 1, radiolabeled with [α-32 P]dUTP, were reacted with ∼1 µg of each GST fusion protein (shown in C) in 400 ml of RBB (100 mM NaCl) for 10 min at 4_C. Bound fractions were analyzed on an 8% sequencing gel. Two bands were detected in all lanes containing RNA due to a specific degradation event in the probe-making procedure. Fyn is a cellular component of signal transduction pathways, and was used as a control for non-specific binding. (C) GST fusion proteins. Approximately 1 µg of each GST fusion protein, as determined by Pierce BCA protein assays, was resolved by 14% SDS-PAGE and subsequently stained with Coomassie blue. The low production of full-length SMN (visible at the top of the gel as a faint band) in E.coli is a result of the poly-proline region in SMN. (D) One microgram of each GST fusion protein was reacted with equivalent amounts of [α-32 P]dUTP-labeled RNA transcribed from the pcDNA3 polylinker in 150, 250, 350 and 500 mM NaCl RBB, as described above. Bound fractions were analyzed by scintillation counting. Values shown represent three individual experiments and are relative to GST-Fyn RNA binding which served as a background control (SMN: 504 ± 87; 461 ± 82; 173 ± 14; 10 ± 3; U1A, 395 ± 59; 328 ± 102; 71 ± 9; 21 ± 2). 
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To determine whether SMN possessed additional nucleic acid-binding properties, the series of GST fusion proteins described above were assayed for their ability to bind DNA. A single-stranded DNA (ssDNA) oligonucleotide comprised of the last 24 nucleotides of SMN exon 2 was radiolabeled with [γ-32 P]dATP and incubated with ∼1 µg of each fusion protein.
Similar to the results obtained for SMN RNA binding, all constructs containing SMN exon 2 bound substantial amounts of ssDNA ( Fig. 2A , lanes 1, 4-6 and 8), while the C-terminal region of SMN was not required for ssDNA binding. This interaction was resistant to NaCl concentrations up to 200 mM ( Fig. 2B ), suggesting a relatively strong association between SMN and ssDNA.
In similar in vitro binding assays, SMN exon 2 also mediated substantial double-stranded DNA (dsDNA)-binding activity (Fig. 3A, lanes 1, 4-6 and 8 ). The SMN-dsDNA complex was resistant to NaCl concentrations up to 170 mM but was not detectable above 200 mM ( Fig. 3B ). Taken together, these data identify a potent, non-sequence-specific NBD within exon 2-encoded SMN (63 amino acids) that is capable of associating to similar degrees with RNA, ssDNA and dsDNA.
Ninety five percent of SMA alleles exhibit deletions of at least SMN tel exon 7 (8); however, a few missense mutations have been identified within SMN exons 6 and 7. This region recently has been shown to mediate SMN self-association, and a direct correlation between disease severity and defects in SMN self-association has been observed (14) . To determine whether the previously reported SMN missense mutations isolated from SMA patients affected RNA binding, in vitro-generated wildtype SMN, S262I (a mutation from a type I SMA patient) and Y272C (a mutation from a type II patient) ( Fig. 4, lanes 5-8) proteins were reacted with poly(rG) beads, as described above. The introduction of the S262I mutation into an otherwise wild-type SMN background resulted in nearly a 3-fold decrease in relative binding efficiency, and the S272I mutation resulted in nearly a 2-fold decrease in relative binding efficiency (Fig. 4,  lanes 1-3) . Interestingly, a correlation between SMA disease severity and RNA-binding activity can be observed, suggesting that SMN-RNA binding activity is functionally relevant. While these mutations fall outside of the minimal SMN NBD, the mutations significantly decrease SMN's ability to self-oligomerize, which in turn, probably indirectly, affects SMN nucleic acid-binding activity. The loss of activity is probably not due to a gross alteration of the protein structure, since these mutants retain binding activity to the wild-type SMN protein (14) .
Exon 3 of SMN contains weak homology to the Drosophila Tudor domain (15) , and exon 6 and 7 contain 'Y/G' motifs (exon 6) (15). These two domains are found in some RNA-binding proteins. The speculation that these domains might bind RNA or nucleic acids was not confirmed in our studies. Database analysis of the N-terminal portion of SMN exon 2 using Smith-Waterman similarity searches demonstrated that across several species, this portion of the SMN NBD was nearly identical (Fig. 5A) , strongly suggesting that this region is functionally significant. Interestingly, several types of HMG proteins, potent nucleic acid-binding proteins, possessed >30% identity/60% similarity to SMN exon 2 (Fig. 5B) . HMG proteins contain a 'HMG-box', a conserved motif that mediates ssDNA-and dsDNA-binding activity (approximately amino acids 5-75) (16) , part of which SMN exon 2 is homologous. While the functional role of the three types of Figure 2B except the binding substrate was as in (A), and binding was performed in the presence of 50 mM NaCl when indicated.
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A SMN-nucleic acid binding has yet to be determined, it is interesting to note that HMGs bind ssDNA and dsDNA.
DISCUSSION
In this report, in vitro binding studies were utilized to demonstrate the nucleic acid-binding properties of the SMN protein. Neither the highly conserved Y/G motifs identified within the C-terminal region spanning exons 6 and 7 (16) , nor the Tudor homology domain located within exon 3 (15) were required for SMNnucleic acid binding. Tudor domains, named after the Drosophila developmental factor tudor, are found within numerous RNAbinding proteins; however, it remains unclear whether this motif is directly involved in RNA binding or whether it functions indirectly, perhaps by providing protein-protein interactions and/or RNA transport. These motifs have been implicated in RNA binding within other proteins; however, SMN exon 2 was necessary and sufficient to mediate substantial levels of SMN binding to RNA, ssDNA and dsDNA templates. Additionally, SMN exon 6 was predicted to bind RNA; however, this region was not required directly for nucleic acid-binding activities.
Since SMN has been shown to associate with factors that form protein-RNA complexes (12, 13) , SMN's subcellular localization, including gems, may be mediated in part by a nucleic acid intermediate. Additionally, since the SMN NBD partially overlaps the SIP1-interaction domain, the NBD is likely to mediate, directly or indirectly, the association with U1 and U5 snRNAs and their subsequent nuclear translocation.
Through an interaction with SIP1, SMN performs a critical function in spliceosomal small nuclear ribonucleoprotein (snRNP) biogenesis (12, 13) , and has been implicated in cellular RNA processing (11) . Previously, SMN was shown to be complexed with RNAs in an SMN-SIP-1-snRNA (U1 and U5, specifically) complex (12, 13) ; however, RNA-binding activity within SMN had not been shown previously. Here, direct nucleic acid-binding activity was identified within SMN exon 2. It remains a formal possibility that the binding activity observed is mediated by an associated factor. However, the data presented strongly suggest that SMN possesses intrinsic nucleic acidbinding activity since SMN generated in eukaryotic extracts, as well as bacterially expressed and purified SMN, exhibited nucleic acid-binding activity. While the data presented here describe only non-sequence-specific nucleic acid binding by SMN, the identification of SMN sequence specificity currently is being investigated.
The reduced RNA-binding activity of the SMN missense mutations suggests that loss of this function may contribute to the pathogenesis of SMA, as evidenced by the correlation between SMA disease severity and the ability of SMN mutant proteins to bind RNA. This defect is likely to be a consequence of the reduced self-association of the mutant SMN proteins (14) . The fact that the mutants retain RNA-binding activity, albeit at reduced levels, suggests that monomeric forms of SMN may retain low level nucleic acid-binding activity. It is also possible that binding to RNA contributes to and stabilizes SMN protein self-association. Our data demonstrate that wild-type, self- In vitro binding was performed as described in Figure 1A using in vitro-generated wild-type SMN, missense mutations (S262I, Y272C), and luciferase reacted with poly(rG)-Sepharose in 500 mM NaCl RBB. Relative binding efficiency values shown were calculated based on the percentage bound relative to the amount of input (SMN wild-type, 75 ± 2%; S262I, 27 ± 3%; Y272C, 55 ± 4%), and represent three independent experiments. association-competent SMN protein optimally binds nucleic acid. In the experiments in which the SMN oligomerization domain was absent ( Fig. 2 and 3) , the dimerization-competent GST protein probably compensates for its absence.
While the SMN C-terminus is the most highly conserved region across species, exon 2 sequences are also well conserved across species, including human, rat, mouse and Caenorhabditis elegans, suggesting that the NBD is functionally significant. A Smith-Waterman-based homology search was performed on the NBD (SMN exon 2), revealing extensive similarity to several classes of nucleic acid-binding factors, including several HMG proteins (Fig. 5 ). Since HMG proteins are known to mediate DNA bending, by analogy, SMN may also bind its target RNA or DNA, thereby allowing the proper configuration of its binding substrates, such as the highly structured snRNA molecules (12, 13) .
The extent of the biological contribution nucleic acid-binding activity makes regarding α-motor neuron-specific or general SMN function remains to be determined. However, due to the essential role(s) of SMN (17) , it is conceivable that several types of nucleic acid-binding may play a role in one or more of SMN functions. Further characterization of SMN nucleic acid-binding activity and the elucidation of consensus binding sequences are critical areas of investigation. While SMN has been shown to be involved in snRNP biogenesis (12, 13) , and to act synergistically with the anti-apoptotic factor Bcl-2 (18), these activities cannot fully explain the highly temporally and spatially restricted defect associated with SMN in SMA. The identification of specific RNA or DNA recognition motifs may provide important insight into a specific gene or class of genes targeted for SMN regulation, which in SMA become dysregulated, giving rise to an α-motor neuron-specific defect.
MATERIALS AND METHODS

Plasmids
GST expression vectors, GST-SMN, GST-Ex1-4, GST-Ex6 and GST-Ex6,7 were described previously (14) . The following oligonucleotide pairs were used to PCR amplify the indicated SMN exons from full-length SMN cDNA which were cloned into pGEX2T 
In vitro binding assays
GST fusion proteins were purified from BL21(DE3)pLysS E.coli transformed with the pGEX2T-SMN and derivative plasmids. Total protein concentrations were determined by Pierce BCA protein assays and confirmed by visualizing ∼1 µg of each fusion protein following SDS-PAGE analysis and Coomassie blue staining. For RNA binding, ∼1 µg of each fusion protein was reacted with equivalent amounts (∼10 ng) of radiolabeled RNA substrate in 400 µl of RNA binding buffer [RBB: 150 mM NaCl; 20 mM Tris (pH 7.5); 1 mM dithiothreitol (DTT); 0.2% Nonidet P-40 (NP-40)] at 4_C for 10 min. Bound fractions were washed five times in 800 µl of pre-chilled RBB, pelleted, released from the fusion protein-bead by boiling in denaturing dye, and subsequently run on an 8% sequencing gel. For DNA binding, ∼1 µg of each fusion protein was reacted with equivalent amounts (∼10 ng) of radiolabeled ssDNA substrate in 400 µl of DNA binding buffer (DBB: 100 mM NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, 1% glycerol, 1% NP-40) at 4_C for 20 min. Bound fractions were washed five times in 800 µl of DBB, pelleted, released from the fusion protein-bead by boiling, and run on 10% non-denaturing PAGE. dsDNA binding was performed as described for ssDNA binding except that ∼30 ng of radiolabeled dsDNA substrate was used, and bound fractions were released from the fusion protein-bead by a 15 min incubation at 65_C. In binding assays involving salt gradients ( Figs 2B and 3B) , the binding reactions contained the NaCl concentration indicated.
RNA homopolymers were analyzed using radiolabeled fulllength SMN protein and mutants generated using the T7 transcription-translation (TnT) rabbit reticulocyte lysate system (Promega) with translation grade [ 35 S]methionine (NEN). In vitro translated products were standardized by analysis prior to binding experiments on SDS-PAGE, and quantitated using the Bio-Rad Molecular Imager G250. Equivalent amounts of the agarose bead-linked RNA homopolymers were reacted with TnT SMN or luciferase in 400 µl of RBB as described above. Bound radiolabeled fractions were released from the agarose bead-RNA by boiling in SDS dye and resolved by 14% SDS-PAGE. Relative binding efficiency (Fig. 4) was calculated by determining the percentage bound to poly(rG) beads of each in vitro-generated Chironomus tentans (midge) (HMG-A). Amino acid identity between aligned proteins is represented by a solid line, and homology is represented by a dashed line. Percentage similarity and percentage identity are as follows (respectively): HMG-D: 61%, 33%; HMG-A: 67%, 31%; HMG-Z: 58%, 34%. The exon 2a-b juncture is indicated by an arrow. The position of amino acids (relative to the first amino acid in SMN exon 2) and the initiating methionine within the various HMG proteins aligned are indicated by numbers to the left of the alignment.
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protein. Mutant SMN binding values are expressed relative to wild-type SMN, which was assigned a value of 1.00.
In vitro binding substrates
The RNA-binding substrate was the sense strand of SMN exon 1, or the pcDNA3 polylinker, radiolabeled using [α-32 P]dUTP in vitro using a XhoI linear pcDNA3 plasmid with or without the SMN exon 1 sequences downstream of the T7 promoter, as described previously (19) . The ssDNA-binding substrate was an oligonucleotide corresponding to the last 24 nucleotides of SMN exon 2, that was end-labeled using T4 polynucleotide kinase and [γ-32 P]dATP. The dsDNA-binding substrate was a BamHI-XhoI dsDNA fragment containing SMN exons 1-2 restricted from the pGEX:GST Ex1-2 plasmid. [α-32 P]dCTP and Klenow were used to radiolabel the gel-purified substrate.
